Enrolling by Invitation
A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia
NCT07521683
- Conditions
- Schizophrenia(Acute)
- Locations
-
- NeuShen Shanghai, China